Home › Acute Lymphoblastic Leukemia › NCT03898596

Umbilical Vessel Catheterization Under ECG Monitoring and Guidance

Who can join

1 Day – 45 Days · All sexes

Inclusion Criteria:

* Neonate pediatric patient
* 2 - 6kg
* Require or currently have UVC

Exclusion Criteria:

* Participants who do not consent or have parental consent
* Patients who are clinically unstable

About the study

Umbilical venous catheters (UVC) are typically places with poor guidance and some radiological confirmation. Misplacement of the catheter could lead to its placement in other unintended anatomical areas such as the liver or the spleen, which could be detrimental in critically-ill infants. Our study aims at using a more non-invasive means of placing and continuously monitoring catheter placement using superficial electrocardiogram (ECG) tracings.

What is being tested

• ECG (diagnostic test)

Sponsor: Stanford University · Participants: 150 · Started: Aug 25, 2020

Contact the study team

• Chynna Villanueva, BS, RN · Phone: 6504986346

Official record on ClinicalTrials.gov — NCT03898596

Locations in the U.S.

Conditions

• Acute Lymphoblastic Leukemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.